MINNEAPOLIS– U.S. Customs and Border Protection (CBP) officers at Minneapolis-St. Paul Airport recently stopped a shipment filled with 2,536 pre-filled syringes of private partsl tightening gel. On November 20, CBP …
Topic:
injectable
-
-
Bausch + Lomb Announces Scientific Data on XIPERE® (Triamcinolone Acetonide Injectable Suspension) to be Presented During the American Society of Retina Specialists Annual Scientific Meeting
by Your NewsFive Presentations Will Highlight Findings from the XIPERE® Pivotal Phase 3 Program VAUGHAN, ON, July 6, 2022 — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global …
-
Avet Pharmaceuticals Announces Approval and Launch of Propofol Injectable Emulsion, USP
by Your NewsAvet Pharma Announces Approval and Launch of Propofol Injectable Emulsion, USP to address current market shortage Tweet this About Propofol Propofol injectable emulsion is an intravenous general anesthetic and sedation …
-
Injectable Drug Delivery Market Size to Reach USD 83.38 Billion in 2030 | Convenience and At-Home Accessibility Afforded by Injectable Pharmaceuticals are Key Factors Driving Industry Demand, Says Emergen Research
by Your NewsVANCOUVER, BC, March 30, 2022 — The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the …
-
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
by Your News“XIPERE® is the first and only therapy available in the United States that utilizes the suprachoroidal space to treat patients who struggle with macular edema associated with uveitis, which is …